ArticleTobacco induced diseases2026
Investigation of smoking cessation intention and the associated factors in patients diagnosed with chronic obstructive pulmonary disease: A cross-sectional study.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIntention to quit is an important early step and a strong predictor of smoking cessation success. In this study, individuals with chronic obstructive pulmonary disease (COPD) were evaluated with a newly developed scale for patients' intention to quit smoking using the current COPD staging system.
methodsThis cross-sectional study was conducted in Gaziantep, Turkey, from 1 March to 1 December 2024, and included 160 people with COPD who currently smoke, to investigate factors associated with smoking cessation intention using a questionnaire. Patients attending the chest diseases outpatient clinic were evaluated through face-to-face interviews using a structured questionnaire assessing demographic, clinical, and disease-specific measures. Shortness of breath was assessed using the modified Medical Research Council (mMRC) score, and COPD symptoms were evaluated using the COPD Assessment Test (CAT). COPD staging was performed according to the Global Initiative for Obstructive Lung Disease (GOLD) 2023 guidelines. Additionally, the Fagerström test for nicotine dependence and the Smoking Cessation Intention Scale were employed. GOLD staging (A, B, E) was defined as: GOLD A (≤1 non-hospitalized exacerbation, mMRC 0-1, CAT <10); GOLD B (mMRC ≥2 and/or CAT ≥10); and GOLD E (≥2 moderate or ≥1 hospitalized exacerbations).Descriptive statistics, non-parametric tests (Mann-Whitney U and Kruskal-Wallis), and Spearman's rho correlation were used. In addition, generalized linear regression model (GLM) was applied.
resultsThe mean age of the patients was 59.43 ± 10.54 years; 148 patients (92.5%) were male, and 104 patients (65%) had primary education. A weak but significant positive correlation was found between the Smoking Cessation Scale scores and both CAT (r=0.245, p=0.002) and mMRC scores (r=0.164, p=0.039). Lower cessation scores were significantly associated with single status (p=0.009), no quit attempts in the last year (p<0.001), lack of information about smoking cessation methods (p=0.016), absence of intention to quit smoking (p<0.001), lack of knowledge that smoking causes heart disease (p=0.035), and GOLD stage A (p=0.001). In the multivariate GLM analysis conducted with eight variables that were found to be significantly associated with the smoking cessation intention score in univariate analyses, three factors remained statistically significant: being married compared to being single (B=4.958; 95% CI: 1.203-8.714, p=0.010), having knowledge about smoking cessation methods compared to not having such knowledge (B=2.432; 95% CI: 0.192-4.672, p=0.033), and having the intention to quit smoking compared to lacking such intention (B=3.327; 95% CI: 1.117-5.536, p=0.003).
conclusionsPhysicians should assess quit-smoking intention factors in COPD patients who continue smoking and should consider these factors in cessation interventions and referrals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.